[MCOH-EH] Accepting COVID vaccinations not FDA approved for international workers?

Charles Hackett dickenshackett at gmail.com
Wed Jan 5 12:58:09 PST 2022


We follow the cdc guidance and use WHO approved
I have copied and pasted here
People who received COVID-19 vaccine outside the United States

There are three scenarios outlined below.

   1. People who were vaccinated outside the United States with a currently
   FDA-approved or FDA-authorized COVID-19 vaccine who:
      - Received all of the recommended doses of a single dose or 2-dose
      primary COVID-19 vaccine series are considered fully vaccinated
      <https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html>
2
      weeks after completion of the series. People who are moderately
or severely
      immunocompromised and were vaccinated with a 2-dose mRNA COVID-19 vaccine
      primary series should receive an additional primary dose as
detailed in Considerations
      for COVID-19 vaccination in moderately or severely
immunocompromised people
      <https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#considerations-covid19-vax-immunocopromised>.
      People vaccinated with an FDA-approved or FDA-authorized COVID-19 vaccine
      outside the United States should also follow guidance for
booster doses as
      detailed in the Booster dose
      <https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#booster-dose>
      .
      - Received the first dose of a 2-dose mRNA COVID-19 vaccine series do
      not need to restart the vaccine series in the United States. They
      should complete the series with an mRNA vaccine as close to the
recommended
      time as possible and are considered fully vaccinated upon
completion of the
      2-dose primary series. People who were vaccinated in countries
where only a
      single mRNA dose is recommended in certain populations (e.g.,
persons with
      a history of SARS-CoV-2 infection, adolescents) are not considered fully
      vaccinated
      <https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html>
in
      the United States until after completion of the 2-dose series.
   2. People who completed all of the recommended doses of a COVID-19
   vaccine listed for emergency use by WHO
   <https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#foot-04>
but
   not approved or authorized by FDA, or people who completed a heterologous
   (mix and match) series composed of doses of a COVID-19 vaccine listed
   for emergency use by WHO
   <https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#foot-04>,
   at least one of which is a non-FDA-approved or authorized vaccine, are
   considered fully vaccinated
   <https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html>
2
   weeks after completion of the series.
      - Under the EUI
      <https://wwwdev.cdc.gov/vaccines/covid-19/eui/index.html>, moderately
      or severely immunocompromised people ≥12 years of age should receive an
      additional primary dose of Pfizer-BioNTech COVID-19 Vaccine (30 µg
      formulation at least 28 days after receiving the second vaccine dose of
      their primary series as detailed in Considerations for COVID-19
      vaccination in moderately or severely immunocompromised people
      <https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#considerations-covid19-vax-immunocopromised>
      .
      - Under the EUI
      <https://wwwdev.cdc.gov/vaccines/covid-19/eui/index.html>, people ≥18
      years of age (including moderately or severely immunocompromised
people who
      received an additional primary dose) should receive a single booster dose
      of Pfizer-BioNTech COVID-19 Vaccine (30 µg formulation [purple or gray
      cap]) at least 6 months after completing their primary series,
as detailed
      in the Booster dose
      <https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#booster-dose>
Those
      who are 16 or 17 years old may get a booster dose.
   3. People who received only the first dose of a multidose WHO-EUL
   COVID-19 primary series4
   <https://wwwdev.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#foot-04>
that
   is not FDA-approved or FDA-authorized, or who received all or some of the
   recommended doses of a COVID-19 vaccine primary series that is not listed
   for emergency use by WHO:
      - Should be offered primary vaccination with an FDA-approved or
      FDA-authorized COVID-19 vaccine (i.e., 2-dose mRNA series or
single Janssen
      dose), with a minimum interval of at least 28 days since receipt of the
      last dose of a non-FDA-approved/authorized vaccine.
      - After completion of primary vaccination with an FDA-approved or
      FDA-authorized COVID-19 vaccine, these individuals are considered fully
      vaccinated
      <https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html>,
      and are not recommended to receive an additional primary or
booster dose at
      this time.



On Wed, Jan 5, 2022 at 3:41 PM Thorne, Craig via MCOH-EH <mcoh-eh at mylist.net>
wrote:

> Happy new year All,
>
> Does anyone have experience and an approach to whether you accept COVID
> vaccine series for international workers coming into the US who have
> received non-FDA approved vaccine brands?
>
> Thank you,
> Craig D. Thorne, M.D.
> Sent from my iPhone
>
>
>
> This message originates from the Yale New Haven Health System. The
> information contained in this message may be privileged and confidential.
> If you are the intended recipient you must maintain this message in a
> secure and confidential manner. If you are not the intended recipient,
> please notify the sender immediately and destroy this message. Thank you.
>
>
> ---------------------------------------
> The MCOH-EH List has always been moderated by members of the ACOEM Medical
> Center Occupational Health Section. It is currently moderated by Joe
> Fanucchi MD FACOEM.
> List membership is free, but only subscribers may post to the list.
> To post send messages to: mcoh-eh at mylist.net
> To become a subscriber, or to change your subscription options (turn off
> email while you're on vacation, etc):   http://www.mcoh-eh.net
> MediTrax / Occupational Health Systems, Inc. provides financial support to
> ensure the list remains a free resource for the occupational health
> community.
> ---------------------------------------
> List archives (public): http://mylist.net/archives/mcoh-eh/
> ---------------------------------------
> Send administrative requests to: drjoe at meditrax.com
> ---------------------------------------
> When replying to a message, PLEASE delete all footers, and all messages to
> which you're NOT replying.
>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mylist.net/archives/mcoh-eh/attachments/20220105/762c5d9d/attachment-0001.htm>


More information about the MCOH-EH mailing list